VALLEY COTTAGE, N.Y. – The
market of lung cancer surgery has been growing moderately with increasing prevalence
of lung cancer, especially in China, Japan, and the US. Market players are
developing robotics-enabled lung cancer surgical techniques that ensure faster
recovery time, and minimum invasion. Companies, including Medtronic, and
Johnson & Johnson, are extending the applicability of surgical devices to urology,
gynecology, and colorectal surgeries. In addition, governments in developed and
developing countries are significantly investing in healthcare sector.
North America and Europe currently hold significant market share on back of increasing healthcare expenditure. Whilst the East Asian market is exhibiting rapid growth owing to expanding patient pool. As per FMI’s new business intelligence report, global lung cancer surgery market is projected to grow at a promising CAGR of ~6% over forecast period (2019-2029).
Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-396
Surgical Energy Instruments at Forefront,
RATSS Witness Faster Adoption
energy instruments remain significantly preferred for performing lung cancer
surgeries through 2029, generating ~US$ 900 Mn. FMI reveals that advanced surgical
energy instruments are expected to hold ~70% of market share. Ultrasonic
instruments will maintain their supremacy throughout forecast period, while
advanced bipolar instruments continue to grow promisingly.
Advent of robotics in healthcare sector has been driving the adoption of robotic-assisted thoracic surgery systems (RATSS), despite the product category generating least revenue. Further, RATSS is estimated to witness notable spike in revenues in present year. In North America and East Asia, surgical energy instruments have generated maximum revenue, while the regions exhibit fastest adoption rate of RATTS.
Preview Analysis of 2019 Analysis and Review of Lung Cancer Surgery Market by Product – Thoracoscope, Mediastinoscope, Bronchoscope, Robotic-assisted Thoracic Surgery System, Surgical Stapler, and Surgical Energy Instrument for 2019 – 2029:https://www.futuremarketinsights.com/reports/lung-cancer-surgery-market
Lobectomy Maintains its Hegemony Throughout
at a promising rate, lobectomy will remain highly-preferred lung cancer surgery,
particularly in developed countries, finds FMI. Further, video-assisted
thoracoscopic surgery (VATS) lobectomy is replacing conventional lobectomy on
back of decreased morbidity, quicker recovery, and shorter hospital stays.
Segmentectomy and wedge resection, on the other hand, are suitable for early stage non-small cell lung cancers. While wedge resection observed notable spike in revenues in 2017, segmentectomy is poised to witness periodic fluctuations. Demand growth for both the techniques remain steady over next decade, collectively contributing to a fourth market share.
Buy this report @ https://www.futuremarketinsights.com/checkout/396
Analysts at FMI opine that “Incidents of lung cancer have been increasing in recent years, as such, need for minimally-invasive advanced lung cancer surgery methods becomes paramount. Market players are integrating robotics with existing surgery techniques to decrease endoleak complexities. Further, lung cancer surgery market is bolstered by favorable government regulations.”
Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-396
More from Healthcare, Pharmaceuticals and Medical devices :
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Mr. Abhishek Budholiya
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
T (UK): + 44 (0) 20 7692 8790